|
STK38 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.168390E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.475700E-02 |
| Normal-vs-Stage2 |
8.519000E-03 |
| Normal-vs-Stage3 |
7.559800E-02 |
| Normal-vs-Stage4 |
1.118960E-01 |
| Stage1-vs-Stage2 |
1.69329999999412E-06 |
| Stage1-vs-Stage3 |
8.423200E-01 |
| Stage1-vs-Stage4 |
7.953800E-01 |
| Stage2-vs-Stage3 |
2.23579999999446E-05 |
| Stage2-vs-Stage4 |
2.441300E-04 |
| Stage3-vs-Stage4 |
9.222200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.575700E-03 |
| Normal-vs-AfricanAmerican |
9.203800E-01 |
| Normal-vs-Asian |
8.633900E-02 |
| Caucasian-vs-AfricanAmerican |
1.687180E-01 |
| Caucasian-vs-Asian |
7.927800E-01 |
| AfricanAmerican-vs-Asian |
2.556200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.123600E-02 |
| Normal-vs-Female |
2.120200E-01 |
| Male-vs-Female |
2.514600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.092420E-02 |
| Normal-vs-Age(41-60Yrs) |
4.367800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.328600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.088170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.728300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.618200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.605800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.773000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.770400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.720200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.770100E-02 |
| Classical-VS-Follicular |
1.62436730732907E-12 |
| Classical-VS-Other |
5.743600E-01 |
| Classical-VS-Normal |
8.603000E-04 |
| Tall-VS-Follicular |
2.01279992673165E-10 |
| Tall-VS-Other |
1.592980E-01 |
| Tall-VS-Normal |
1.209650E-04 |
| Follicular-VS-Other |
3.349700E-02 |
| Follicular-VS-Normal |
3.39440000551861E-08 |
| Other-VS-Normal |
4.934800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.155200E-01 |
| Normal-vs-N1 |
5.074200E-02 |
| N0-vs-N1 |
1.140100E-02 |
|
|
